Haematological Parameters in People with Atherosclerotic Cardiovascular Disease versus Those Who are Only at Risk for

Ebsitu Abate1, Maria Degef1, Addisu Melkie2

  • 1Department of Medical Biochemistry Addis Ababa University, Addis Ababa, Ethiopia.

Insights

Elevated mean platelet volume (MPV) is linked to atherosclerotic cardiovascular disease (ASCVD) risks. This common hematological parameter, along with hs-CRP, may help predict ASCVD risk and morbidity.

Area of Science:

  • Cardiology
  • Hematology
  • Biochemistry

Background:

  • Cardiovascular disease (CVD), particularly atherosclerotic cardiovascular disease (ASCVD), is a leading global cause of mortality.
  • ASCVD is associated with numerous risk factors including hypertension, diabetes, dyslipidemia, and smoking.
  • These risk factors and ASCVD itself can disrupt physiological functions, notably affecting hematological parameters.

Purpose of the Study:

  • To compare hematological parameter patterns in patients with established ASCVD versus those with ASCVD risk factors alone.
  • To investigate the correlation between hematological parameters and the inflammatory marker high-sensitivity C-reactive protein (hs-CRP) in these groups.

Main Methods:

  • A prospective, cross-sectional comparative study involving 100 participants was conducted.
  • Hematological parameters, lipids, and hs-CRP levels were determined from blood samples.
  • Socio-demographic data were collected using a structured questionnaire.

Main Results:

  • The group with ASCVD risk factors exhibited significantly higher mean platelet volume (MPV) compared to the ASCVD group.
  • A significant positive correlation was observed between hs-CRP levels and MPV.
  • MPV emerged as a potential indicator associated with ASCVD risk.

Conclusions:

  • Mean platelet volume (MPV) may serve as a valuable, accessible biomarker for identifying individuals at risk for ASCVD.
  • Routine hematological tests, including MPV, could aid in assessing ASCVD risk and morbidity.
  • Further research is needed to clarify the role of hs-CRP in relation to ASCVD cases versus controls.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
203
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
370
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
201
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
123
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25